VCNX
Vaccinex, Inc.Company with tickers: VCNX
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $601,000 | USD | 2024-12-31 | 10-K | 2025-04-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $12,545,000 | USD | 2024-12-31 | 10-K | 2025-04-15 |
| Operating Income | $-18,735,000 | USD | 2024-12-31 | 10-K | 2025-04-15 |
| Net Income | $-18,634,000 | USD | 2024-12-31 | 10-K | 2025-04-15 |
| EPS (Basic) | $-8.88 | USD/shares | 2024-12-31 | 10-K | 2025-04-15 |
| EPS (Diluted) | $-8.88 | USD/shares | 2024-12-31 | 10-K | 2025-04-15 |